CAREDX, INC. Remaining Share Repurchase Authorization
CAREDX, INC. (CDNA) had Remaining Share Repurchase Authorization of $50.00 million as of 2025-02-20, per its 10-Q filed 2025-04-30.
Financial Statements › Notes › Equity
us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1 · last filed 2025-04-30
- 2025-02-20: Stock Repurchase Program, Remaining Authorized Repurchase Amount $50.00M.
- 2024-09-30: Stock Repurchase Program, Remaining Authorized Repurchase Amount $21.40M.
- 2024-06-30: Stock Repurchase Program, Remaining Authorized Repurchase Amount $21.40M.
- 2024-03-31: Stock Repurchase Program, Remaining Authorized Repurchase Amount $21.40M.
| Period end | Stock Repurchase Program, Remaining Authorized Repurchase Amount |
|---|---|
| 2025-02-20 | $50.00M 10-Q · filed 2025-04-30 |
| 2024-09-30 | $21.40M 10-Q · filed 2024-11-04 |
| 2024-06-30 | $21.40M 10-Q · filed 2024-07-31 |
| 2024-03-31 | $21.40M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $21.90M 10-K · filed 2024-02-28 |
| 2023-09-30 | $47.70M 10-Q · filed 2023-11-08 |
| 2023-06-30 | $48.60M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $48.70M 10-Q · filed 2023-05-10 |
| 2022-12-31 | $49.40M 10-K · filed 2023-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| BIODESIX INC (BDSX) | United States | $0.312B |